In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Brought to you by

Endologix buys Nellix Endovascular

Executive Summary

Endologix Inc. (minimally invasive aortic disorder treatments) has agreed to acquire closely held Nellix Endovascular Inc. (abdominal aortic aneurysm (AAA) devices) for $15mm in stock, plus an earn-out of up to $39mm in shares.
Deal Industry
  • Medical Devices
  • Medical Devices
    • Implantable Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
      • Surgical Sealants
Deal Status
  • Final
Deal Type
  • Acquisition
    • Full Acquisition
    • Includes Contract
    • Includes Earnout
    • Payment Includes Stock

Related Companies

UsernamePublicRestriction

Register